Craft

Outset Medical

Stock Price

$0.6

2024-10-29

Market Capitalization

$28.8 M

2024-10-29

Revenue

$119.5 M

FY, 2025

Outset Medical Summary

Company Summary

Overview
Outset Medical (formerly known as HD+) is a medical technology company that develops hemodialysis systems. It offers Tablo, a dialysis machine that allows nurses to manage hemodialysis treatments. The company also provides online resources and e-learning modules.
Type
Public
Status
Active
Founded
2003
HQ
San Jose, CA, US | view all locations
Website
https://outsetmedical.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Nabeel Ahmed

    Nabeel Ahmed, Chief Financial Officer

  • Michael Aragon

    Michael Aragon, Chief Medical Officer

  • John Brottem
  • Patrick T. Hackett

Operating MetricsView all

Remaining Performance Obligations

$11.8M
34.1%

FY, 2023

Suppliers

200

FY, 2023

LocationsView all

1 location detected

  • San Jose, CA HQ

    United States

    3052 Orchard Drive

Outset Medical Financials

Summary Financials

Revenue (Q1, 2026)
$27.9M
Gross profit (Q1, 2026)
$12.1M
Net income (Q1, 2026)
($19.0M)
Cash (Q1, 2026)
$30.6M
EBIT (Q1, 2026)
($16.9M)
Enterprise value
$99.8M

Footer menu